Greater patient access to immuno-oncology therapies-what can policymakers do?
Ecancermedicalscience
.
2015 Feb 25:9:ed48.
doi: 10.3332/ecancer.2015.ed48.
eCollection 2015.
Authors
Francesco de Lorenzo
1
,
Suzanne Wait
2
,
Burçak Karaca
3
,
Cedrik M Britten
4
,
Marc van den Bulcke
5
;
European Expert Group on Immuno-Oncology
Affiliations
1
European Cancer Patient Coalition, Brussels B-1000, Belgium.
2
The Health Policy Partnership, London W1W 5NA, UK.
3
Ege University, Department of Medical Oncology, Izmir 35100, Turkey.
4
Association for Cancer Immunotherapy (CIMT), Mainz D-55116, Germany.
5
Scientific Institute of Public Health, B-1050, Belgium.
PMID:
25729428
PMCID:
PMC4342084
DOI:
10.3332/ecancer.2015.ed48
No abstract available